MedPath

DFB Soria, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

2 Phases

Phase 1:1
Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (66.7%)
Phase 1
1 (33.3%)

Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN)

Phase 2
Withdrawn
Conditions
Cervical Intraepithelial Neoplasia
Interventions
Drug: SOR007 (Uncoated Nanoparticulate Paclitaxel) Ointment
First Posted Date
2017-05-08
Last Posted Date
2017-10-18
Lead Sponsor
DFB Soria, LLC
Registration Number
NCT03143491

Study of SOR007 Ointment for Actinic Keratosis

Phase 2
Completed
Conditions
Actinic Keratosis
Interventions
Drug: SOR007 (Uncoated Nanoparticulate Paclitaxel) Ointment
Other: SOR007 Ointment Vehicle
First Posted Date
2017-03-20
Last Posted Date
2019-05-15
Lead Sponsor
DFB Soria, LLC
Target Recruit Count
33
Registration Number
NCT03083470
Locations
🇺🇸

Moore Clinical Research, Tampa, Florida, United States

Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test

Phase 1
Completed
Conditions
Plaque Psoriasis
Interventions
Drug: SOR007 Ointment 2.0%
Drug: SOR007 Ointment 1.0%
Drug: SOR007 Ointment 0.3%
Drug: SOR007 Ointment 0.15%
Drug: SOR007 Ointment Placebo
First Posted Date
2016-12-28
Last Posted Date
2019-02-15
Lead Sponsor
DFB Soria, LLC
Target Recruit Count
13
Registration Number
NCT03004339
Locations
🇺🇸

DermResearch, Inc., Austin, Texas, United States

🇺🇸

J&S Studies, Inc., College Station, Texas, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.